Inhibrx Biosciences Inc.

NASDAQ:INBX   4:00:00 PM EDT
14.76
-0.12 (-0.81%)
4:01:43 PM EDT: $14.76 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Inhibrx Biosciences Inc. Stock, NASDAQ:INBX

11025 North Torrey Pines Road, Suite 140, La Jolla, California 92037
United States of America
Phone: +1.858.795.4220
Number of Employees:

Description

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded on January 8, 2024 and is headquartered in La Jolla, CA.